BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1984 related articles for article (PubMed ID: 17157294)

  • 21. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury.
    Schulz R; Wambolt R
    Cardiovasc Res; 1995 Sep; 30(3):432-9. PubMed ID: 7585835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global myocardial ischemia protects the myocardium from subsequent regional ischemia.
    Walker DM; Walker JM; Yellon DM
    Cardioscience; 1993 Dec; 4(4):263-6. PubMed ID: 8298068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
    Salloum F; Yin C; Xi L; Kukreja RC
    Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotected warm ischaemia.
    Hallström S; Franz M; Gasser H; Vodrazka M; Semsroth S; Losert UM; Haisjackl M; Podesser BK; Malinski T
    Cardiovasc Res; 2008 Feb; 77(3):506-14. PubMed ID: 18006447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart.
    Brunner F
    J Mol Cell Cardiol; 1997 Sep; 29(9):2363-74. PubMed ID: 9299360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.
    Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R
    J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts.
    Der P; Cui J; Das DK
    J Mol Cell Cardiol; 2006 Feb; 40(2):313-20. PubMed ID: 16337960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide.
    Szigeti Z; Simon K; Parratt JR; Végh A
    Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation.
    Jin ZQ; Karliner JS; Vessey DA
    Cardiovasc Res; 2008 Jul; 79(1):134-40. PubMed ID: 18334546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.
    Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A
    Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance to ischaemia and ischaemic preconditioning in neonatal rat heart.
    Ostadalova I; Ostadal B; Kolár F; Parratt JR; Wilson S
    J Mol Cell Cardiol; 1998 Apr; 30(4):857-65. PubMed ID: 9602435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac and coronary function in the Langendorff-perfused mouse heart model.
    Reichelt ME; Willems L; Hack BA; Peart JN; Headrick JP
    Exp Physiol; 2009 Jan; 94(1):54-70. PubMed ID: 18723581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
    Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
    Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ischemic preconditioning of the myocardium: the role of changes in the permeability of the coronary microcirculation].
    Di Napoli P; Di Muzio M; Contegiacomo G; Tiloca P; Spoletini L; Di Crecchio A; Gallina S; Barsotti A
    Cardiologia; 1997 Jan; 42(1):59-67. PubMed ID: 9118156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of 17beta-estradiol on myocardial inducible NOS and endothelial NOS activities after ischemia-reperfusion in rat heart model].
    Wang XD; Wang ZM; Jia DL; Yu P
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1789-91. PubMed ID: 17919391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heightened alpha1A-adrenergic receptor activity suppresses ischaemia/reperfusion-induced Ins(1,4,5)P3 generation in the mouse heart: a comparison with ischaemic preconditioning.
    Amirahmadi F; Turnbull L; Du XJ; Graham RM; Woodcock EA
    Clin Sci (Lond); 2008 Jan; 114(2):157-64. PubMed ID: 17696883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
    Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    du Toit EF; Nabben M; Lochner A
    Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model.
    Leprán I; Pollesello P; Vajda S; Varró A; Papp JG
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):148-52. PubMed ID: 17086092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 100.